(Q43266647)

17 November 2017

Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis (English)

1 reference

17 November 2017

0 references

0 references

Mitchell A Watsky

8

0 references

author name string

Kathryn M Ryder

1

1 reference

17 November 2017

S Bobo Tanner

2

1 reference

17 November 2017

Laura Carbone

3

1 reference

17 November 2017

John E Williams

4

1 reference

17 November 2017

Henry M Taylor

5

1 reference

17 November 2017

Andrew Bush

6

1 reference

17 November 2017

Victorina Pintea

7

1 reference

17 November 2017

6 October 2009

1 reference

Journal of Bone and Mineral Metabolism

17 November 2017

1 reference

17 November 2017

28

1 reference

17 November 2017

2

1 reference

17 November 2017

233-239

1 reference

https://scigraph.springernature.com/pub.10.1007/s00774-009-0123-1

17 November 2017

0 references

cites work

Respiratory disease mortality in an institutionalised mentally retarded population

1 reference

12 December 2020

Mechanisms of osteoporosis in spinal cord injury

1 reference

12 December 2020

Fracture incidence and bone disease in epileptics receiving long-term anticonvulsant drug treatment

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study

1 reference

12 December 2020

Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal

1 reference

12 December 2020

The risk of renal calculi in spinal cord injury patients.

1 reference

12 December 2020

Screening for osteoporosis in community-dwelling adults with mental retardation

1 reference

12 December 2020

Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis

1 reference

12 December 2020

Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort

1 reference

12 December 2020

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis

1 reference

12 December 2020

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

1 reference

12 December 2020

Appendicular fractures: a significant problem among institutionalized adults with developmental disabilities.

1 reference

12 December 2020

Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest.

1 reference

12 December 2020

The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis

1 reference

12 December 2020

Imaging ultrasonometry of the calcaneus: optimum T-score thresholds for the identification of osteoporotic subjects

1 reference

12 December 2020

Prevalence of feeding problems and oral motor dysfunction in children with cerebral palsy: a community survey

1 reference

12 December 2020

Development of an algorithm for using PINP to monitor treatment of patients with teriparatide.

1 reference

12 December 2020

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

12 December 2020

Prevention of bone loss in paraplegics over 2 years with alendronate

1 reference

12 December 2020

Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats

1 reference

12 December 2020

The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis

1 reference

12 December 2020

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial

1 reference

12 December 2020

Clinical use of bone densitometry: scientific review

1 reference

12 December 2020

Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial

1 reference

12 December 2020

Long-term disuse osteoporosis seems less sensitive to bisphosphonate treatment than other osteoporosis

1 reference

12 December 2020

10.1007/S00774-009-0123-1

Identifiers

DOI

1 reference

Dimensions Publication ID

17 November 2017

0 references

1 reference